Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$17.42M
58 trades · 11 insiders
Net · 90d
$-17.42M
Insiders on file
32
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| MPM BioVentures 2018 GP LLC | 10% Owner | 5 | $0 | $2.82M | 2026-09-09 |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | 17 | $2.00M | $3.60M | 2026-09-09 |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | 3 | $0 | $1.91M | 2026-09-09 |
| MPM BioVentures 2014, L.P. | 10% Owner | 12 | $0 | $3.60M | 2026-09-09 |
| MPM BioVentures 2018 LLC | 10% Owner | 9 | $0 | $1.69M | 2026-09-03 |
| MPM BioVentures 2014 GP LLC | 10% Owner | 3 | $0 | $617.4K | 2026-09-03 |
| Sethuraman Natarajan | President, Research & Develop. | 54 | $0 | $1.90M | 2026-09-02 |
| Dowden Nathan J | President & COO | 69 | $0 | $1.90M | 2026-09-02 |
| WENTWORTH KORY JAMES | Chief Financial Officer | 116 | $0 | $1.91M | 2026-09-02 |
| Doshi Dipal | President and CEO | 84 | $0 | $1.39M | 2026-09-02 |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | 3 | $0 | $615.8K | 2026-08-31 |
| Foley Todd | Director, 10% Owner | 10 | $2.00M | $461.5K | 2026-08-26 |
| PARMAR KUSH | Director, 10% Owner | 35 | $5.00M | $6.60M | 2026-08-10 |
| 5AM Ventures V, L.P. | 10% Owner | 5 | $0 | $3.00M | 2026-08-07 |
| ROCKLAGE SCOTT M | 10% Owner | 4 | $0 | $1.24M | 2026-08-07 |
| Radhakrishnan Maha | Director | 2 | $0 | $0 | 2026-06-10 |
| Chapman Gina | Director | 4 | $0 | $0 | 2026-06-10 |
| Zeiher Bernhardt G | Director | 5 | $29.3K | $0 | 2026-06-10 |
| Thistle Mary | Director | 6 | $0 | $0 | 2026-06-10 |
| KIM PETER S | Director | 21 | $1.37M | $0 | 2026-06-10 |
| BAKER FELIX | 10% Owner | 4 | $261.8K | $0 | 2025-11-20 |
| Baker Bros. Advisors (GP) LLC | 10% Owner | 18 | $1.61M | $0 | 2025-11-12 |
| 5AM Opportunities I, L.P. | 10% Owner | 2 | $0 | $202.5K | 2025-07-09 |
| Schwab Andrew J. | 10% Owner | 17 | $5.00M | $866.5K | 2025-07-01 |
| MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | 10% Owner | 2 | $0 | $917.1K | 2024-12-11 |
| BAKER BROS. ADVISORS LP | 10% Owner | 20 | $50.71M | $0 | 2024-06-25 |
| KREHER NERISSA | Chief Medical Officer | 65 | $0 | $998.2K | 2023-09-06 |
| Crowley John F | Director | 4 | $48.6K | $0 | 2023-06-08 |
| Nuechterlein Carole | Director | 2 | $0 | $0 | 2022-06-02 |
| ROCHE HOLDING LTD | 10% Owner | 4 | $0 | $0 | 2021-11-02 |
| MPM Asset Management Investors BV2014 LLC | 10% Owner | 5 | $2.00M | $0 | 2021-11-02 |
| Redmile Group, LLC | 10% Owner | 3 | $20.00M | $0 | 2021-11-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| MPM BIOVENTURES 2018 (B), L.P. | 10% Owner | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| MPM BioVentures 2014 GP LLC | 10% Owner | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 1,733 | $7.14 | $12.4K | 117,277 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | F Tax w/h | 2026-09-02 | 2026-09-03 | 2,079 | $7.14 | $14.8K | 214,238 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2026-09-02 | 2026-09-03 | 2,528 | $7.14 | $18.0K | 196,060 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2026-09-02 | 2026-09-03 | 8,724 | $7.14 | $62.3K | 517,290 | SEC↗ |
| MPM BioVentures 2014 GP LLC | 10% Owner | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | F Tax w/h | 2026-09-02 | 2026-09-03 | 2,079 | $7.14 | $14.9K | 214,238 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 1,733 | $7.14 | $12.4K | 117,277 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2026-09-02 | 2026-09-03 | 2,528 | $7.14 | $18.1K | 196,060 | SEC↗ |
| Doshi Dipal | CEO, Director | F Tax w/h | 2026-09-02 | 2026-09-03 | 8,724 | $7.14 | $62.3K | 517,290 | SEC↗ |
| MPM BioVentures 2014 GP LLC | 10% Owner | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| Foley Todd | 10% Owner | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| Foley Todd | 10% Owner | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| MPM BioVentures 2018 LLC | 10% Owner | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| Foley Todd | 10% Owner | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| MPM BioVentures 2014, L.P. | 10% Owner | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| PARMAR KUSH | Director | S Sale | 2026-08-10 | 2026-08-10 | 92,444 | $7.00 | $647.1K | 2,691,337 | SEC↗ |
| PARMAR KUSH | Director | S Sale | 2026-08-10 | 2026-08-10 | 92,444 | $7.00 | $647.1K | 2,691,337 | SEC↗ |
| ROCKLAGE SCOTT M | 10% Owner | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| PARMAR KUSH | Director | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| PARMAR KUSH | Director | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| 5AM Ventures V, L.P. | 10% Owner | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| ROCKLAGE SCOTT M | 10% Owner | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| PARMAR KUSH | Director | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| PARMAR KUSH | Director | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| 5AM Ventures V, L.P. | 10% Owner | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| ROCKLAGE SCOTT M | 10% Owner | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| 5AM Ventures V, L.P. | 10% Owner | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| ROCKLAGE SCOTT M | 10% Owner | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| 5AM Ventures V, L.P. | 10% Owner | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| Zeiher Bernhardt G | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Thistle Mary | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Radhakrishnan Maha | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Chapman Gina | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| KIM PETER S | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Zeiher Bernhardt G | Director | P Buy | 2026-05-20 | 2026-05-21 | 5,000 | $5.86 | $29.3K | 5,000 | SEC↗ |
| Dowden Nathan J | President & COO | M Exercise deriv | 2026-05-04 | 2026-05-04 | 15,000 | — | $0 | 49,831 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2026-05-04 | 2026-05-04 | 15,000 | $15.33 | $229.9K | 198,588 | SEC↗ |
| Dowden Nathan J | President & COO | M Exercise | 2026-05-04 | 2026-05-04 | 15,000 | $1.74 | $26.1K | 213,588 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2026-05-04 | 2026-05-04 | 25,907 | $15.39 | $398.7K | 216,317 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2026-04-01 | 2026-04-02 | 2,500 | $12.95 | $32.4K | 119,010 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2026-03-10 | 2026-03-11 | 11,388 | $13.02 | $148.3K | 121,510 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2026-03-10 | 2026-03-11 | 11,894 | $13.05 | $155.2K | 198,588 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2026-03-09 | 2026-03-11 | 5,089 | $13.00 | $66.2K | 132,898 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2026-03-09 | 2026-03-11 | 3,116 | $13.02 | $40.6K | 210,482 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2026-03-04 | 2026-03-06 | 7,988 | $12.25 | $97.9K | 137,987 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | F Tax w/h | 2026-03-03 | 2026-03-03 | 7,577 | $11.76 | $89.1K | 242,224 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2026-03-03 | 2026-03-03 | 14,038 | $11.76 | $165.1K | 213,598 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2026-03-03 | 2026-03-03 | 5,712 | $11.76 | $67.2K | 145,975 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2026-03-03 | 2026-03-03 | 19,181 | $11.76 | $225.6K | 526,014 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | F Tax w/h | 2026-03-02 | 2026-03-03 | 3,898 | $11.66 | $45.5K | 249,801 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2026-03-02 | 2026-03-03 | 7,223 | $11.66 | $84.2K | 227,636 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2026-03-02 | 2026-03-03 | 2,939 | $11.66 | $34.3K | 151,687 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2026-03-02 | 2026-03-03 | 9,869 | $11.66 | $115.1K | 545,195 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | A Award deriv | 2026-03-01 | 2026-03-03 | 83,200 | — | $0 | 83,200 | SEC↗ |
| Dowden Nathan J | President & COO | A Award deriv | 2026-03-01 | 2026-03-03 | 83,200 | — | $0 | 83,200 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 66,600 | — | $0 | 66,600 | SEC↗ |
| Doshi Dipal | CEO | A Award deriv | 2026-03-01 | 2026-03-03 | 208,000 | — | $0 | 208,000 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | A Award | 2026-03-01 | 2026-03-03 | 55,800 | — | $0 | 253,699 | SEC↗ |
| Dowden Nathan J | President & COO | A Award | 2026-03-01 | 2026-03-03 | 55,800 | — | $0 | 234,859 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | A Award | 2026-03-01 | 2026-03-03 | 44,600 | — | $0 | 154,626 | SEC↗ |
| Doshi Dipal | CEO | A Award | 2026-03-01 | 2026-03-03 | 139,400 | — | $0 | 555,064 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2025-11-21 | 2025-11-24 | 8,910 | $9.98 | $88.9K | 110,026 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2025-11-20 | 2025-11-24 | 1,213 | $9.07 | $11.0K | 380,152 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2025-11-20 | 2025-11-24 | 13,386 | $9.07 | $121.4K | 4,678,310 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2025-11-20 | 2025-11-24 | 1,186 | $9.07 | $10.8K | 381,338 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2025-11-20 | 2025-11-24 | 13,082 | $9.07 | $118.7K | 4,691,392 | SEC↗ |
| 5AM Ventures V, L.P. | 10% Owner | S Sale | 2025-11-14 | 2025-11-18 | 200,000 | $8.80 | $1.76M | 2,963,066 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-11-14 | 2025-11-18 | 200,000 | $8.80 | $1.76M | 2,963,066 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-12 | 2025-11-12 | 1,040 | $7.95 | $8.3K | 378,939 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-12 | 2025-11-12 | 80,881 | $7.73 | $625.2K | 4,653,430 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-12 | 2025-11-12 | 7,321 | $7.73 | $56.6K | 377,899 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-12 | 2025-11-12 | 11,494 | $7.95 | $91.4K | 4,664,924 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-11 | 2025-11-12 | 1,059 | $7.39 | $7.8K | 367,783 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-11 | 2025-11-12 | 30,879 | $7.54 | $232.8K | 4,572,549 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-11 | 2025-11-12 | 2,795 | $7.54 | $21.1K | 370,578 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-11 | 2025-11-12 | 11,701 | $7.39 | $86.5K | 4,541,670 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-10 | 2025-11-12 | 2,296 | $7.21 | $16.6K | 366,457 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-10 | 2025-11-12 | 25,364 | $7.21 | $182.9K | 4,527,022 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-10 | 2025-11-12 | 267 | $7.22 | $1.9K | 366,724 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | 10% Owner | P Buy | 2025-11-10 | 2025-11-12 | 2,947 | $7.22 | $21.3K | 4,529,969 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,734 | $5.43 | $9.4K | 118,936 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,760 | $5.43 | $9.6K | 197,899 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,746 | $5.43 | $9.5K | 179,059 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2025-09-02 | 2025-09-04 | 8,723 | $5.43 | $47.4K | 415,664 | SEC↗ |
| 5AM Opportunities I, L.P. | 10% Owner | S Sale | 2025-07-09 | 2025-07-11 | 6,935 | $7.50 | $52.0K | 1,093,313 | SEC↗ |
| 5AM Opportunities I, L.P. | 10% Owner | S Sale | 2025-07-09 | 2025-07-11 | 20,065 | $7.50 | $150.5K | 3,163,066 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-07-09 | 2025-07-11 | 6,935 | $7.50 | $52.0K | 1,093,313 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-07-09 | 2025-07-11 | 20,065 | $7.50 | $150.5K | 3,163,066 | SEC↗ |
| Schwab Andrew J. | 10% Owner | S Sale | 2025-07-01 | 2025-07-01 | 18,578 | $7.12 | $132.3K | 3,183,131 | SEC↗ |
| Schwab Andrew J. | 10% Owner | S Sale | 2025-07-01 | 2025-07-01 | 6,422 | $7.12 | $45.7K | 1,100,248 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-07-01 | 2025-07-01 | 18,578 | $7.12 | $132.3K | 3,183,131 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-07-01 | 2025-07-01 | 6,422 | $7.12 | $45.7K | 1,100,248 | SEC↗ |
| Schwab Andrew J. | 10% Owner | S Sale | 2025-06-30 | 2025-07-01 | 6,422 | $6.81 | $43.7K | 1,106,670 | SEC↗ |
| Schwab Andrew J. | 10% Owner | S Sale | 2025-06-30 | 2025-07-01 | 18,578 | $6.81 | $126.5K | 3,201,709 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-06-30 | 2025-07-01 | 18,578 | $6.81 | $126.5K | 3,201,709 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-06-30 | 2025-07-01 | 6,422 | $6.81 | $43.7K | 1,106,670 | SEC↗ |
| Schwab Andrew J. | 10% Owner | S Sale | 2025-06-27 | 2025-07-01 | 19,265 | $6.91 | $133.1K | 1,113,092 | SEC↗ |
| Schwab Andrew J. | 10% Owner | S Sale | 2025-06-27 | 2025-07-01 | 55,735 | $6.91 | $385.1K | 3,220,287 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-06-27 | 2025-07-01 | 55,735 | $6.91 | $385.1K | 3,220,287 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2025-06-27 | 2025-07-01 | 19,265 | $6.91 | $133.1K | 1,113,092 | SEC↗ |
| Chapman Gina | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Zeiher Bernhardt G | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Thistle Mary | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| KIM PETER S | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | A Award deriv | 2025-06-11 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Radhakrishnan Maha | Director | A Award deriv | 2025-06-01 | 2025-06-03 | 38,000 | — | $0 | 38,000 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2025-04-03 | 2025-04-04 | 11,134 | — | $0 | 20,023 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2025-04-03 | 2025-04-04 | 11,134 | $2.10 | $23.4K | 120,670 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2025-03-17 | 2025-03-19 | 1,784 | $10.67 | $19.0K | 109,536 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | F Tax w/h | 2025-03-03 | 2025-03-04 | 6,138 | $11.68 | $71.7K | 199,659 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2025-03-03 | 2025-03-04 | 5,144 | $11.68 | $60.1K | 180,805 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2025-03-03 | 2025-03-04 | 4,929 | $11.68 | $57.6K | 111,320 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2025-03-03 | 2025-03-04 | 17,566 | $11.68 | $205.2K | 424,387 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | A Award deriv | 2025-03-01 | 2025-03-04 | 90,800 | — | $0 | 90,800 | SEC↗ |
| Dowden Nathan J | President & COO | A Award deriv | 2025-03-01 | 2025-03-04 | 90,800 | — | $0 | 90,800 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | A Award deriv | 2025-03-01 | 2025-03-04 | 63,300 | — | $0 | 63,300 | SEC↗ |
| Doshi Dipal | CEO | A Award deriv | 2025-03-01 | 2025-03-04 | 173,400 | — | $0 | 173,400 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | A Award | 2025-03-01 | 2025-03-04 | 60,800 | — | $0 | 205,797 | SEC↗ |
| Dowden Nathan J | President & COO | A Award | 2025-03-01 | 2025-03-04 | 60,800 | — | $0 | 185,949 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | A Award | 2025-03-01 | 2025-03-04 | 42,400 | — | $0 | 116,249 | SEC↗ |
| Doshi Dipal | CEO | A Award | 2025-03-01 | 2025-03-04 | 116,200 | — | $0 | 441,953 | SEC↗ |
| MPM ASSET MANAGEMENT INVESTORS | 10% Owner | S Sale | 2024-12-11 | 2024-12-12 | 21,787 | $20.23 | $440.8K | 4,381,062 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2024-12-11 | 2024-12-12 | 21,787 | $20.23 | $440.8K | 4,381,062 | SEC↗ |
| MPM ASSET MANAGEMENT INVESTORS | 10% Owner | S Sale | 2024-12-10 | 2024-12-12 | 22,935 | $20.77 | $476.4K | 4,402,849 | SEC↗ |
| MPM BioVentures 2018 GP LLC | 10% Owner | S Sale | 2024-12-10 | 2024-12-12 | 22,935 | $20.77 | $476.4K | 4,402,849 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-12-03 | 2024-12-03 | 11,703 | $20.15 | $235.8K | 144,997 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2024-12-02 | 2024-12-03 | 5,000 | — | $0 | 31,157 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-12-02 | 2024-12-03 | 4,088 | $20.26 | $82.8K | 156,700 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2024-12-02 | 2024-12-03 | 5,000 | $20.00 | $100.0K | 73,849 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2024-12-02 | 2024-12-03 | 5,000 | $2.10 | $10.5K | 78,849 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2024-11-29 | 2024-12-03 | 1,000 | — | $0 | 36,157 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-11-29 | 2024-12-03 | 100 | $20.00 | $2.0K | 160,788 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2024-11-29 | 2024-12-03 | 1,000 | $2.10 | $2.1K | 74,849 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2024-11-29 | 2024-12-03 | 1,000 | $19.97 | $20.0K | 73,849 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-11-13 | 2024-11-13 | 2,700 | $20.04 | $54.1K | 160,888 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2024-11-11 | 2024-11-13 | 6,000 | — | $0 | 37,157 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2024-11-11 | 2024-11-13 | 8,637 | $19.98 | $172.6K | 73,849 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2024-11-11 | 2024-11-13 | 6,000 | $2.10 | $12.6K | 82,486 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-11-11 | 2024-11-13 | 1,409 | $20.01 | $28.2K | 163,588 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-11-06 | 2024-11-06 | 2,745 | $19.32 | $53.0K | 164,997 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-11-06 | 2024-11-06 | 9,554 | $18.71 | $178.8K | 167,742 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-11-05 | 2024-11-06 | 5,171 | $18.18 | $94.0K | 177,296 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-11-04 | 2024-11-06 | 749 | $18.02 | $13.5K | 182,467 | SEC↗ |
| Sethuraman Natarajan | President, Research & Develo | S Sale | 2024-10-16 | 2024-10-18 | 600 | $18.00 | $10.8K | 183,216 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2024-09-26 | 2024-09-30 | 847 | $16.00 | $13.6K | 125,149 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | S Sale | 2024-09-09 | 2024-09-10 | 2,642 | $15.09 | $39.9K | 183,816 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2024-09-09 | 2024-09-10 | 1,904 | $15.07 | $28.7K | 125,996 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2024-09-09 | 2024-09-10 | 3,195 | $14.97 | $47.8K | 76,486 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | S Sale | 2024-09-06 | 2024-09-10 | 600 | $15.24 | $9.1K | 186,458 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2024-09-06 | 2024-09-10 | 399 | $15.19 | $6.1K | 127,900 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-09-05 | 2024-09-05 | 165 | $15.13 | $2.5K | 79,681 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-09-05 | 2024-09-05 | 167 | $15.13 | $2.5K | 187,058 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-09-05 | 2024-09-05 | 171 | $15.13 | $2.6K | 128,299 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-09-05 | 2024-09-05 | 826 | $15.13 | $12.5K | 325,753 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-09-04 | 2024-09-05 | 941 | $15.42 | $14.5K | 79,846 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-09-04 | 2024-09-05 | 955 | $15.42 | $14.7K | 187,225 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-09-04 | 2024-09-05 | 983 | $15.42 | $15.2K | 128,470 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-09-04 | 2024-09-05 | 4,744 | $15.42 | $73.2K | 326,579 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-09-03 | 2024-09-05 | 14 | $17.70 | $248 | 80,787 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-09-03 | 2024-09-05 | 149 | $16.93 | $2.5K | 80,801 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-09-03 | 2024-09-05 | 462 | $15.76 | $7.3K | 80,950 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-09-03 | 2024-09-05 | 14 | $17.70 | $248 | 188,180 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-09-03 | 2024-09-05 | 469 | $15.76 | $7.4K | 188,345 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-09-03 | 2024-09-05 | 151 | $16.93 | $2.6K | 188,194 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-09-03 | 2024-09-05 | 483 | $15.76 | $7.6K | 129,624 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-09-03 | 2024-09-05 | 156 | $16.93 | $2.6K | 129,468 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-09-03 | 2024-09-05 | 15 | $17.70 | $266 | 129,453 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-09-03 | 2024-09-05 | 2,328 | $15.76 | $36.7K | 332,147 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-09-03 | 2024-09-05 | 752 | $16.93 | $12.7K | 331,395 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-09-03 | 2024-09-05 | 72 | $17.70 | $1.3K | 331,323 | SEC↗ |
| Dowden Nathan J | President & COO | M Exercise deriv | 2024-08-16 | 2024-08-20 | 20,000 | — | $0 | 64,831 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2024-08-16 | 2024-08-20 | 502 | $16.70 | $8.4K | 130,107 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2024-08-16 | 2024-08-20 | 26,595 | $16.26 | $432.4K | 130,609 | SEC↗ |
| Dowden Nathan J | President & COO | M Exercise | 2024-08-16 | 2024-08-20 | 20,000 | $1.74 | $34.8K | 157,204 | SEC↗ |
| Doshi Dipal | CEO | S Sale | 2024-07-15 | 2024-07-16 | 1,600 | $17.81 | $28.5K | 334,475 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | S Sale | 2024-07-15 | 2024-07-16 | 638 | $18.00 | $11.5K | 188,814 | SEC↗ |
| Doshi Dipal | CEO | S Sale | 2024-07-12 | 2024-07-16 | 300 | $18.00 | $5.4K | 336,075 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | S Sale | 2024-07-12 | 2024-07-16 | 600 | $18.00 | $10.8K | 189,452 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2024-07-08 | 2024-07-10 | 1,758 | $14.95 | $26.3K | 81,412 | SEC↗ |
| BAKER BROS. ADVISORS LP | 10% Owner | P Buy deriv | 2024-06-25 | 2024-06-26 | 3,081,303 | $14.85 | $45.76M | 3,081,303 | SEC↗ |
| BAKER BROS. ADVISORS LP | 10% Owner | P Buy deriv | 2024-06-25 | 2024-06-26 | 285,700 | $14.85 | $4.24M | 285,700 | SEC↗ |
| Chapman Gina | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Zeiher Bernhardt G | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Thistle Mary | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KIM PETER S | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | A Award deriv | 2024-06-13 | 2024-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Doshi Dipal | CEO | S Sale | 2024-06-13 | 2024-06-14 | 1,000 | $16.17 | $16.2K | 336,375 | SEC↗ |
| KIM PETER S | Director | M Exercise deriv | 2024-06-03 | 2024-06-05 | 11,918 | — | $0 | 0 | SEC↗ |
| KIM PETER S | Director | M Exercise | 2024-06-03 | 2024-06-05 | 11,918 | $6.06 | $72.2K | 104,330 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | S Sale | 2024-05-20 | 2024-05-20 | 9,675 | $15.19 | $147.0K | 190,052 | SEC↗ |
| Doshi Dipal | CEO | S Sale | 2024-05-17 | 2024-05-20 | 1,200 | $15.11 | $18.1K | 337,375 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | S Sale | 2024-05-17 | 2024-05-20 | 8,305 | $15.14 | $125.7K | 199,727 | SEC↗ |
| Doshi Dipal | CEO | S Sale | 2024-05-16 | 2024-05-20 | 1,800 | $15.00 | $27.0K | 338,575 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | S Sale | 2024-05-16 | 2024-05-20 | 1,000 | $15.00 | $15.0K | 208,032 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-05-14 | 2025-06-18 | 25,000 | $14.59 | $364.8K | 117,412 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-05-14 | 2024-05-16 | 25,000 | $14.59 | $364.8K | 92,412 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-05-13 | 2025-06-18 | 25,000 | $14.68 | $367.0K | 92,412 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-05-09 | 2024-05-10 | 2,200 | $14.25 | $31.4K | 67,412 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-05-08 | 2024-05-10 | 2,276 | $14.04 | $32.0K | 65,212 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-04-08 | 2024-04-10 | 2,600 | $13.57 | $35.3K | 62,936 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-03-28 | 2024-04-01 | 1,512 | $13.75 | $20.8K | 60,336 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-03-26 | 2024-03-26 | 2,750 | $13.64 | $37.5K | 58,824 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-03-25 | 2024-03-26 | 3,180 | $13.36 | $42.5K | 56,074 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-03-22 | 2024-03-26 | 3,118 | $13.76 | $42.9K | 52,894 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-03-21 | 2024-03-21 | 704 | $13.24 | $9.3K | 49,776 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-03-20 | 2024-03-21 | 1,128 | $12.66 | $14.3K | 49,072 | SEC↗ |
| KIM PETER S | Director | P Buy | 2024-03-19 | 2024-03-21 | 900 | $12.66 | $11.4K | 47,944 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2024-03-15 | 2024-03-19 | 9,000 | — | $0 | 43,157 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2024-03-15 | 2024-03-19 | 9,000 | $2.10 | $18.9K | 83,170 | SEC↗ |
| Dowden Nathan J | President & COO | S Sale | 2024-03-06 | 2024-03-08 | 1,826 | $12.32 | $22.5K | 137,204 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2024-03-06 | 2024-03-08 | 4,086 | $12.31 | $50.3K | 74,170 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-03-05 | 2024-03-05 | 1,505 | $12.28 | $18.5K | 209,032 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-03-05 | 2024-03-05 | 1,486 | $12.28 | $18.2K | 139,030 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-03-05 | 2024-03-05 | 1,471 | $12.28 | $18.1K | 78,256 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-03-05 | 2024-03-05 | 5,049 | $12.28 | $62.0K | 340,375 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-03-04 | 2024-03-05 | 414 | $13.37 | $5.5K | 210,537 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | F Tax w/h | 2024-03-04 | 2024-03-05 | 347 | $12.42 | $4.3K | 210,951 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-03-04 | 2024-03-05 | 343 | $12.42 | $4.3K | 140,925 | SEC↗ |
| Dowden Nathan J | President & COO | F Tax w/h | 2024-03-04 | 2024-03-05 | 409 | $13.37 | $5.5K | 140,516 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-03-04 | 2024-03-05 | 339 | $12.42 | $4.2K | 80,132 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | F Tax w/h | 2024-03-04 | 2024-03-05 | 405 | $13.37 | $5.4K | 79,727 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-03-04 | 2024-03-05 | 1,391 | $13.37 | $18.6K | 345,424 | SEC↗ |
| Doshi Dipal | CEO | F Tax w/h | 2024-03-04 | 2024-03-05 | 1,164 | $12.42 | $14.5K | 346,815 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 66,800 | — | $0 | 66,800 | SEC↗ |
| Dowden Nathan J | President & COO | A Award deriv | 2024-03-01 | 2024-03-05 | 50,100 | — | $0 | 50,100 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 46,800 | — | $0 | 46,800 | SEC↗ |
| Doshi Dipal | CEO | A Award deriv | 2024-03-01 | 2024-03-05 | 158,500 | — | $0 | 158,500 | SEC↗ |
| Sethuraman Natarajan | Chief Scientific Officer | A Award | 2024-03-01 | 2024-03-05 | 44,100 | — | $0 | 211,298 | SEC↗ |
| Dowden Nathan J | President & COO | A Award | 2024-03-01 | 2024-03-05 | 33,100 | — | $0 | 81,268 | SEC↗ |
| Dowden Nathan J | President & COO | A Award | 2024-03-01 | 2024-03-05 | 60,000 | — | $0 | 141,268 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | A Award | 2024-03-01 | 2024-03-05 | 30,900 | — | $0 | 80,471 | SEC↗ |
| Doshi Dipal | CEO | A Award | 2024-03-01 | 2024-03-05 | 104,700 | — | $0 | 347,979 | SEC↗ |
| Doshi Dipal | CEO | S Sale | 2024-02-15 | 2024-02-20 | 1,000 | $15.00 | $15.0K | 243,279 | SEC↗ |
| Doshi Dipal | CEO | S Sale | 2024-01-16 | 2024-01-18 | 1,000 | $15.99 | $16.0K | 244,279 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2023-12-26 | 2023-12-26 | 94 | — | $0 | 52,157 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2023-12-26 | 2023-12-26 | 94 | $2.10 | $197 | 49,665 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2023-12-26 | 2023-12-26 | 94 | $16.67 | $1.6K | 49,571 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2023-12-22 | 2023-12-26 | 10,206 | — | $0 | 52,251 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2023-12-22 | 2023-12-26 | 10,206 | $2.10 | $21.4K | 59,777 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2023-12-22 | 2023-12-26 | 3,677 | $16.48 | $60.6K | 49,571 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2023-12-22 | 2023-12-26 | 6,529 | $15.24 | $99.5K | 53,248 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise deriv | 2023-12-21 | 2023-12-26 | 2,200 | — | $0 | 62,457 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2023-12-21 | 2023-12-26 | 2,200 | $15.07 | $33.2K | 49,571 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | M Exercise | 2023-12-21 | 2023-12-26 | 2,200 | $2.10 | $4.6K | 51,771 | SEC↗ |
| Doshi Dipal | President and CEO | S Sale | 2023-12-20 | 2023-12-22 | 1,000 | $15.00 | $15.0K | 245,279 | SEC↗ |
| Doshi Dipal | President and CEO | S Sale | 2023-11-13 | 2023-11-13 | 1,000 | $16.23 | $16.2K | 246,279 | SEC↗ |
| Doshi Dipal | President and CEO | S Sale | 2023-10-17 | 2023-10-19 | 1,000 | $15.00 | $15.0K | 247,279 | SEC↗ |
| Doshi Dipal | President and CEO | S Sale | 2023-09-13 | 2023-09-15 | 1,000 | $15.00 | $15.0K | 248,279 | SEC↗ |
| Dowden Nathan J | Chief Operating Officer | S Sale | 2023-09-06 | 2023-09-06 | 59 | $14.01 | $827 | 48,168 | SEC↗ |
| Dowden Nathan J | Chief Operating Officer | S Sale | 2023-09-06 | 2023-09-06 | 913 | $13.43 | $12.3K | 48,227 | SEC↗ |
| KREHER NERISSA | Chief Medical Officer | S Sale | 2023-09-06 | 2023-09-06 | 871 | $13.46 | $11.7K | 40,058 | SEC↗ |
| KREHER NERISSA | Chief Medical Officer | S Sale | 2023-09-06 | 2023-09-06 | 21 | $14.00 | $294 | 40,037 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2023-09-06 | 2023-09-06 | 904 | $13.45 | $12.2K | 49,617 | SEC↗ |
| WENTWORTH KORY JAMES | Chief Financial Officer | S Sale | 2023-09-06 | 2023-09-06 | 46 | $14.03 | $645 | 49,571 | SEC↗ |